Literature DB >> 2707295

Frontal lobe dysfunction in Parkinson's disease: prognostic value for dementia?

M Piccirilli1, P D'Alessandro, G Finali, G L Piccinin, L Agostini.   

Abstract

The purpose of this longitudinal study was to investigate if the presence of frontal motor deficits in parkinsonians without signs of global intellectual impairment may have a predictive value for the development of a progressive dementing process during the course of the illness. An examination of the higher level of motor organization, using skills thought to depend upon the integrity of the frontal regions, was performed by 30 parkinsonian patients who did not present any signs of general intellectual impairment. According to their performance, as compared with controls, they were divided into two subgroups: those with and those without frontal dysfunctions. After a mean period of 4 years, a second neuropsychological examination was carried out to assess any eventual change of mental status. The results suggest that frontal dysfunctions may be observed several years before the appearance of generalized intellectual impairment and may be considered one of the predictive factors for development of dementia in Parkinson's disease. Careful consideration of these defects during examination of motor abilities may be of value in the clinical management of parkinsonian patients.

Entities:  

Mesh:

Year:  1989        PMID: 2707295     DOI: 10.1159/000116381

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  12 in total

1.  Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?

Authors:  Rachael Purri; Laura Brennan; Jacqueline Rick; Sharon X Xie; Benjamin L Deck; Lana M Chahine; Nabila Dahodwala; Alice Chen-Plotkin; John E Duda; James F Morley; Rizwan S Akhtar; John Q Trojanowski; Andrew Siderowf; Daniel Weintraub
Journal:  Mov Disord       Date:  2020-06-10       Impact factor: 10.338

2.  Alzheimer-type dementia and verbal memory performances: influence of selegiline therapy.

Authors:  G Finali; M Piccirilli; C Oliani; G L Piccinin
Journal:  Ital J Neurol Sci       Date:  1992-03

Review 3.  Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers.

Authors:  Alexander I Tröster
Journal:  Neuropsychol Rev       Date:  2008-03-06       Impact factor: 7.444

Review 4.  Rule-based category learning in patients with Parkinson's disease.

Authors:  Amanda Price; J Vincent Filoteo; W Todd Maddox
Journal:  Neuropsychologia       Date:  2009-02-02       Impact factor: 3.139

5.  Linguistic correlates of asymmetric motor symptom severity in Parkinson's Disease.

Authors:  Thomas Holtgraves; Patrick McNamara; Kevin Cappaert; Raymond Durso
Journal:  Brain Cogn       Date:  2009-09-13       Impact factor: 2.310

6.  Selective bilateral lesion of the globus pallidus: ten-year follow-up of memory impairment and frontal symptomatology.

Authors:  M Piccirilli; P Mazzi; R Luccioli; T Sciarma
Journal:  Ital J Neurol Sci       Date:  1995-12

Review 7.  Mild cognitive impairment exists in Parkinson's disease.

Authors:  Irena Rektorova
Journal:  J Neural Transm (Vienna)       Date:  2011-06-19       Impact factor: 3.575

8.  Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients.

Authors:  Kathy Dujardin; Luc Defebvre; Alain Duhamel; Pascal Lecouffe; Pascal Rogelet; Marc Steinling; Alain Destée
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

9.  Event-related desynchronization/synchronization during discrimination task conditions in patients with Parkinson's disease.

Authors:  Juliana Dushanova; Dolja Philipova; Gloria Nikolova
Journal:  Cell Mol Neurobiol       Date:  2009-03-17       Impact factor: 5.046

10.  Pragmatic comprehension deficit in Parkinson's disease.

Authors:  Thomas Holtgraves; Patrick McNamara
Journal:  J Clin Exp Neuropsychol       Date:  2009-09-17       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.